4basebio PLC
LSE: 4BB.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Amy Jo Walker
- Employees
- 101
- Headquarters
- Cambridge, United Kingdom
- IPO year
- 2021
- Market cap
- £70.5M
- Website
- https://www.4basebio.com
Loading 4BB…
Loading profile data…Frequently asked questions about 4BB
What does 4basebio PLC (4BB.L) do?
4basebio PLC engages in the design, development, manufacturing, and supply of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company provides research kits, bulk enzymes, and other products, as well as licensing services; and AVV manufacturing services. It serves bio...
Where does 4BB.L trade?
4basebio PLC (4BB.L) trades on the London Stock Exchange.
What sector is 4BB.L in?
4basebio PLC (4BB.L) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of 4basebio PLC?
Amy Jo Walker is the chief executive officer of 4basebio PLC (4BB.L).
Where is 4basebio PLC headquartered?
4basebio PLC is headquartered in United Kingdom.
Does 4BB.L pay a dividend?
4basebio PLC (4BB.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4BB.L go public?
4basebio PLC (4BB.L) completed its initial public offering in 2021.